Jun 11
Chewy outlines fiscal 2026 net sales of $13.40B-$13.55B while targeting net leverage below 2x adjusted EBITDA
Synthesized from 4 sources
Sources (4)
Bias Scale:
LeftCenterRight
Seeking AlphaJun 11, 2026, 6:29 AM
BioNxt Solutions announces one-year extension on $4.58M debt; issues 16.9M bonus warrantsSeeking AlphaJun 11, 2026, 6:17 AM
Chewy outlines fiscal 2026 net sales of $13.40B-$13.55B while targeting net leverage below 2x adjusted EBITDASeeking AlphaJun 11, 2026, 5:53 AM
J.Jill reaffirms FY2026 adjusted EBITDA of $70M-$75M while cutting net new store outlook to 1-5Seeking AlphaJun 10, 2026, 11:32 PM
Aethlon outlines Cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advancesComments
No comments yet. Be the first!